FDA approves New Drug Application for Tuzistra XR cough-cold treatment
5 May 2015 | By Victoria White
Vernalis and Tris Pharma have announced that the FDA has approved the New Drug Application for Tuzistra XR extended-release oral suspension...
List view / Grid view
News
First patient receives new ‘resistance-busting’ panRAF inhibitor in skin cancer drug trial
5 May 2015 | By Victoria White
A patient has become the first to receive a new ‘resistance-busting’ panRAF inhibitor with the launch of a phase I clinical trial...
Lilly releases corporate responsibility reports
5 May 2015 | By Victoria White
Eli Lilly and Company has released two new reports that provide a comprehensive overview of the Company's corporate responsibility efforts...
Genocea’s GEN-003 in prime position to lead genital herpes vaccine space, says GlobalData Analyst
30 April 2015 | By Victoria White
Genocea's GEN-003 is better positioned to compete in the future genital herpes treatment space, despite being slightly behind Agenus’ HerpV in development...
WHO coordinating the health response to Nepal earthquake and working to prevent spread of disease
30 April 2015 | By Victoria White
WHO has taken leadership in coordinating medical relief for communities affected by Saturday's devastating earthquake in Nepal...
Professor Alan Boyd elected President of the Faculty of Pharmaceutical Medicine
30 April 2015 | By Victoria White
Professor Alan Boyd, owner of Boyds consultancy business, has been elected as President of the Faculty of Pharmaceutical Medicine...
Xtandi to drive prostate cancer treatment market value to $8.2 Billion by 2023
30 April 2015 | By Victoria White
The market value for prostate cancer will expand more than threefold to an estimated $8.2 billion by 2023, driven by the label extension of Xtandi...
Martindale Pharma expands international business in Asia Pacific
30 April 2015 | By Victoria White
Martindale Pharma today announced the appointment of AFT Pharmaceuticals as its distribution partner for several Asia Pacific markets...
ESCMID announces late-breaking study results at ECCMID
30 April 2015 | By Victoria White
The European Society of Clinical Microbiology and Infectious Disease announced a live update on breaking science emerging at its annual congress, ECCMID...
FDA to review Amgen’s Repatha as a treatment for high cholesterol
30 April 2015 | By Victoria White
The FDA will review data supporting Amgen’s Biologics License Application (BLA) for Repatha (evolocumab) for the treatment of high cholesterol...
CoLucid Pharmaceuticals announces initiation of first Phase 3 pivotal trial of lasmiditan in migraine
30 April 2015 | By Victoria White
CoLucid Pharmaceuticals has announced that the first patient has been randomised in its SAMURAI study, the Company’s Phase 3 pivotal trial of lasmiditan...
FDA accepts supplemental Biologics License Application for Opdivo in patients with previously untreated advanced melanoma
30 April 2015 | By Victoria White
The FDA has accepted for filing and review the sBLA for Opdivo for the treatment of previously untreated patients with unresectable or metastatic melanoma...
Jacketed reactors for any application from Glass Solutions
29 April 2015 | By kdm communications
Glass Solutions has launched a range of jacketed reactor systems combining excellent value with reliable performance for process development, reaction optimization, or production applications...
amp biosimilars AG appoints Rolf G. Werner as Chairman of the Scientific Board
29 April 2015 | By Victoria White
amp biosimilars has announced Professor Dr Rolf G. Werner is to head up the Scientific Board as "Chairman of the Scientific Board", effective immediately...
FDA grants fast track designation to Genzyme’s investigational substrate reduction therapy for the treatment of Fabry disease
29 April 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of Genzyme’s GZ/SAR402671, an investigational substrate reduction therapy for Fabry disease...
